LU84364A1 - Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique - Google Patents

Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique Download PDF

Info

Publication number
LU84364A1
LU84364A1 LU84364A LU84364A LU84364A1 LU 84364 A1 LU84364 A1 LU 84364A1 LU 84364 A LU84364 A LU 84364A LU 84364 A LU84364 A LU 84364A LU 84364 A1 LU84364 A1 LU 84364A1
Authority
LU
Luxembourg
Prior art keywords
methyl
triazole
methanol
pharmaceutical composition
pharmaceutical
Prior art date
Application number
LU84364A
Other languages
English (en)
French (fr)
Inventor
Barry John Price
Roy Thomas Brittain
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of LU84364A1 publication Critical patent/LU84364A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU84364A 1981-09-04 1982-09-03 Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique LU84364A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04
GB8126787 1981-09-04

Publications (1)

Publication Number Publication Date
LU84364A1 true LU84364A1 (fr) 1984-04-24

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84364A LU84364A1 (fr) 1981-09-04 1982-09-03 Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique

Country Status (18)

Country Link
JP (1) JPS5855421A (da)
KR (1) KR840001276A (da)
AU (1) AU8799882A (da)
BE (1) BE894286A (da)
DE (1) DE3232831A1 (da)
DK (1) DK396582A (da)
FI (1) FI823041L (da)
FR (1) FR2512343A1 (da)
GB (1) GB2105588B (da)
GR (1) GR76433B (da)
IL (1) IL66709A0 (da)
IT (1) IT8249072A0 (da)
LU (1) LU84364A1 (da)
NL (1) NL8203456A (da)
PT (1) PT75504A (da)
SE (1) SE8205035L (da)
ZA (1) ZA826479B (da)
ZW (1) ZW18582A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US20110301116A1 (en) * 2008-12-04 2011-12-08 The University Of Tokyo Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3067920D1 (en) * 1979-03-02 1984-06-28 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
US4410523A (en) * 1979-10-22 1983-10-18 Glaxo Group Limited Heterocyclic derivatives

Also Published As

Publication number Publication date
DE3232831A1 (de) 1983-03-24
FR2512343A1 (fr) 1983-03-11
JPS5855421A (ja) 1983-04-01
IT8249072A0 (it) 1982-09-03
GB2105588A (en) 1983-03-30
GR76433B (da) 1984-08-10
AU8799882A (en) 1983-03-10
BE894286A (fr) 1983-03-02
PT75504A (en) 1982-10-01
FI823041A7 (fi) 1983-03-05
FI823041A0 (fi) 1982-09-03
IL66709A0 (en) 1982-12-31
SE8205035L (sv) 1983-03-05
KR840001276A (ko) 1984-04-30
NL8203456A (nl) 1983-04-05
DK396582A (da) 1983-03-05
ZA826479B (en) 1984-04-25
ZW18582A1 (en) 1984-03-28
FI823041L (fi) 1983-03-05
SE8205035D0 (sv) 1982-09-03
GB2105588B (en) 1984-07-18

Similar Documents

Publication Publication Date Title
BE1005086A5 (fr) Compositions pour l'administration buccale.
BE1007268A3 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
EP1108424B1 (fr) Comprimé matriciel permettant la libération prolongée de trimétazidine après administration par voie orale
CH672068A5 (da)
EP0678026A1 (fr) Application de la carbamazepine et de l'oxcarbazepine dans le traitement de la maladie de parkinson et des syndromes parkinsoniens.
CH679373A5 (da)
EP2120956A1 (en) Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
FR2837706A1 (fr) Utilisation d'un antagoniste des recepteurs aux cannabinoides cb1 pour la preparation de medicaments utiles pour traiter les dysfonctionnements sexuels et/ou ameliorer les performances sexuelles
BE897058A (fr) Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
LU84364A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique
BE1007024A5 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1, selective.
CH679553A5 (da)
US4855293A (en) Anti-inflammatory compositions comprising a systemic non-steroidal anti-inflammatory drug and a cyclopentyl ether
FR2512342A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
WO2003035062A1 (fr) Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire
CH678149A5 (da)
FR2627985A1 (fr) Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables
WO2001012265A1 (fr) Utilisation de la cyamemazine dans le traitement du sevrage brutal aux benzodiazepines
FR2812547A1 (fr) Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
FR2834214A1 (fr) Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2832930A1 (fr) Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
FR2832064A1 (fr) Composition pharmaceutique comprenant une glitazone et un derive de thiazolidinedione et son utilisation pour traiter le diabete
MC1114A1 (fr) Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole
FR2822069A1 (fr) Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete
FR2832927A1 (fr) Composition pharmaceutique comprenant un acide 4-oxo-butanoique et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete